Inspire Medical Systems (INSP) reported Q4 preliminary revenue Monday in the range of $268.9 million to $269.1 million, up roughly 12% year over year.

Analysts polled by FactSet expect $262.2 million.

Full-year 2025 revenue is now projected to be in the range of $911.8 million to $912 million, compared with previous outlook of $900 million to $910 million, the company said.

Analysts surveyed by FactSet expect $905.2 million.

For 2026, the company said it continues to expect revenue to grow 10% to 11% to a range of $1.00 billion to $1.01 billion.

Analysts surveyed by FactSet expect $1.01 billion.

Additionally, the company said Matt Osberg has been appointed as chief financial officer, starting Jan. 19.

Osberg was most recently CFO at Apogee Enterprises (APOG), the company said.

Shares of Inspire Medical Systems were up 2% in recent premarket activity Monday.